UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life

Journal of virology, 2020-01, Vol.94 (4)

2020

Volltextzugriff (PDF)

The multifaceted nature of HIV tissue reservoirs

Current opinion in HIV & AIDS, 2024-05, Vol.19 (3), p.116-123

2024

Volltextzugriff (PDF)

PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent

Nanomedicine (London, England), 2022-12, Vol.17 (29), p.2159-2171

2022

Volltextzugriff (PDF)

Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers

AIDS (London), 2014-07, Vol.28 (11), p.1567-1577

2014

Volltextzugriff (PDF)

The Latent Human Immunodeficiency Virus (HIV) Reservoir Resides Primarily in CD32−CD4+ T Cells in Perinatally HIV-Infected Adolescents With Long-Term Virologic Suppression

The Journal of infectious diseases, 2019-01, Vol.219 (1), p.80-88

2019

Volltextzugriff (PDF)

Patients on HAART often have an excess of unintegrated HIV DNA: Implications for monitoring reservoirs

Virology (New York, N.Y.), 2011-01, Vol.409 (1), p.46-53

2011

Volltextzugriff (PDF)

Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs

Journal of virology, 2021-07, Vol.95 (15), p.e0242520-e0242520

2021

Volltextzugriff (PDF)

Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12–15 December 2017, Miami, FL, USA

Journal of Virus Eradication, 2018-04, Vol.4 (2), p.132-142

2018

Volltextzugriff (PDF)

Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses

Cell, 2022-01, Vol.185 (2), p.266-282.e15

2022

Volltextzugriff (PDF)

The impact of immune checkpoint therapy on the latent reservoir in HIV infected individuals with cancer on antiretroviral therapy

AIDS (London), 2021-08, Vol.35 (10), p.1631-1636

2021

Volltextzugriff (PDF)

CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival, quiescence, and stemness

Immunity (Cambridge, Mass.), 2023-05, Vol.56 (5), p.1132-1147.e6

2023

Volltextzugriff (PDF)

Cellular Metabolism Is a Major Determinant of HIV-1 Reservoir Seeding in CD4+ T Cells and Offers an Opportunity to Tackle Infection

Cell metabolism, 2019-03, Vol.29 (3), p.611-626.e5

2019

Volltextzugriff (PDF)

HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections

Immunity (Cambridge, Mass.), 2023-03, Vol.56 (3), p.653-668.e5

2023

Volltextzugriff (PDF)

HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs

Seminars in immunology, 2021-01, Vol.51, p.101438-101438, Article 101438

2021

Volltextzugriff (PDF)

Measuring the contribution of γδ T cells to the persistent HIV reservoir

AIDS (London), 2020-03, Vol.34 (3), p.363-371

2020

Volltextzugriff (PDF)

Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy

Journal of virology, 2019-12, Vol.94 (1)

2019

Volltextzugriff (PDF)

Machine Learning Bolsters Evidence That D1, Nef, and Tat Influence HIV Reservoir Dynamics

Pathogens & immunity, 2024-01, Vol.8 (2), p.37-58

2024

Volltextzugriff (PDF)

Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size During Aging

Clinical infectious diseases, 2022-08, Vol.75 (1), p.73-80

2022

Volltextzugriff (PDF)

Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir

AIDS (London), 2016-03, Vol.30 (5), p.761-769

2016

Volltextzugriff (PDF)

Nanotechnology-based systems for the treatment and prevention of HIV/AIDS

Advanced drug delivery reviews, 2010-03, Vol.62 (4), p.458-477

2010

Volltextzugriff (PDF)

Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?

Current opinion in HIV & AIDS, 2016-07, Vol.11 (4), p.394-401

2016

Volltextzugriff (PDF)

Immunotherapy in People With HIV and Cancer

Frontiers in immunology, 2019-08, Vol.10, p.2060-2060

2019

Volltextzugriff (PDF)

Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children

AIDS (London), 2014-04, Vol.28 (7), p.1015-1020

2014

Volltextzugriff (PDF)

What do we measure when we measure cell-associated HIV RNA

Retrovirology, 2018-01, Vol.15 (1), p.13-13, Article 13

2018

Volltextzugriff (PDF)

1 – 25 von 1.685

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.510)
Mit Volltextzugriff
(1.365)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.303)
EZB Electronic Journals Library
(1.102)
Ingenta
(867)
IngentaConnect Journals
(675)
Journals@Ovid Ovid Full Text
(631)
Publisher website
(358)
Springer Journals
(189)
Access via ScienceDirect (Elsevier)
(183)
JSTOR
(157)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(152)
Access via Oxford University Press
(144)
Oxford Journals 2020 Medicine
(127)
Wiley Online Library
(97)
Access via Taylor & Francis
(89)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(73)
Taylor & Francis
(66)
Nexis Uni
(62)
Wiley Online Library
(60)
Access via Taylor & Francis
(49)
Nature
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life

The multifaceted nature of HIV tissue reservoirs

PolyIC-coated Prussian blue nanoparticles as a dual-mode HIV latency reversing agent

Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers

The Latent Human Immunodeficiency Virus (HIV) Reservoir Resides Primarily in CD32−CD4+ T Cells in Perinatally HIV-Infected Adolescents With Long-Term Virologic Suppression

Patients on HAART often have an excess of unintegrated HIV DNA: Implications for monitoring reservoirs

Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs

Highlights from the 8th International Workshop on HIV Persistence during Therapy, 12–15 December 2017, Miami, FL, USA

Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses

The impact of immune checkpoint therapy on the latent reservoir in HIV infected individuals with cancer on antiretroviral therapy

CD8+ T cells promote HIV latency by remodeling CD4+ T cell metabolism to enhance their survival, quiescence, and stemness

Cellular Metabolism Is a Major Determinant of HIV-1 Reservoir Seeding in CD4+ T Cells and Offers an Opportunity to Tackle Infection

HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections

HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs

Measuring the contribution of γδ T cells to the persistent HIV reservoir

Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART

Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy

Machine Learning Bolsters Evidence That D1, Nef, and Tat Influence HIV Reservoir Dynamics

Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size During Aging

Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir

Nanotechnology-based systems for the treatment and prevention of HIV/AIDS

Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents?

Immunotherapy in People With HIV and Cancer

Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children

What do we measure when we measure cell-associated HIV RNA

Suchergebnisse filtern